-
Je něco špatně v tomto záznamu ?
Disparate HDV ribozyme crystal structures represent intermediates on a rugged free-energy landscape
KN. Sripathi, WW. Tay, P. Banáš, M. Otyepka, J. Šponer, NG. Walter,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem, Research Support, U.S. Gov't, Non-P.H.S.
NLK
Free Medical Journals
od 1995 do Před 6 měsíci
PubMed Central
od 1995 do Před 1 rokem
Europe PubMed Central
od 1995 do Před 1 rokem
Open Access Digital Library
od 1995-03-01
PubMed
24854621
DOI
10.1261/rna.044982.114
Knihovny.cz E-zdroje
- MeSH
- katalytická doména MeSH
- katalýza MeSH
- kinetika MeSH
- konformace nukleové kyseliny MeSH
- krystalografie rentgenová MeSH
- molekulární modely MeSH
- rezonanční přenos fluorescenční energie metody MeSH
- RNA katalytická chemie MeSH
- RNA malá jaderná chemie metabolismus MeSH
- RNA virová chemie MeSH
- simulace molekulární dynamiky MeSH
- štěpení RNA MeSH
- virus hepatitidy delta enzymologie genetika MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
- Research Support, U.S. Gov't, Non-P.H.S. MeSH
The hepatitis delta virus (HDV) ribozyme is a member of the class of small, self-cleaving catalytic RNAs found in a wide range of genomes from HDV to human. Both pre- and post-catalysis (precursor and product) crystal structures of the cis-acting genomic HDV ribozyme have been determined. These structures, together with extensive solution probing, have suggested that a significant conformational change accompanies catalysis. A recent crystal structure of a trans-acting precursor, obtained at low pH and by molecular replacement from the previous product conformation, conforms to the product, raising the possibility that it represents an activated conformer past the conformational change. Here, using fluorescence resonance energy transfer (FRET), we discovered that cleavage of this ribozyme at physiological pH is accompanied by a structural lengthening in magnitude comparable to previous trans-acting HDV ribozymes. Conformational heterogeneity observed by FRET in solution appears to have been removed upon crystallization. Analysis of a total of 1.8 µsec of molecular dynamics (MD) simulations showed that the crystallographically unresolved cleavage site conformation is likely correctly modeled after the hammerhead ribozyme, but that crystal contacts and the removal of several 2'-oxygens near the scissile phosphate compromise catalytic in-line fitness. A cis-acting version of the ribozyme exhibits a more dynamic active site, while a G-1 residue upstream of the scissile phosphate favors poor fitness, allowing us to rationalize corresponding changes in catalytic activity. Based on these data, we propose that the available crystal structures of the HDV ribozyme represent intermediates on an overall rugged RNA folding free-energy landscape.
Department of Medicinal Chemistry University of Michigan Ann Arbor Michigan 48109 1065 USA
Program in Chemical Biology University of Michigan Ann Arbor Michigan 48109 1055 USA
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14074199
- 003
- CZ-PrNML
- 005
- 20161101111628.0
- 007
- ta
- 008
- 141006s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1261/rna.044982.114 $2 doi
- 035 __
- $a (PubMed)24854621
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Sripathi, Kamali N $u Department of Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan 48109-1065, USA.
- 245 10
- $a Disparate HDV ribozyme crystal structures represent intermediates on a rugged free-energy landscape / $c KN. Sripathi, WW. Tay, P. Banáš, M. Otyepka, J. Šponer, NG. Walter,
- 520 9_
- $a The hepatitis delta virus (HDV) ribozyme is a member of the class of small, self-cleaving catalytic RNAs found in a wide range of genomes from HDV to human. Both pre- and post-catalysis (precursor and product) crystal structures of the cis-acting genomic HDV ribozyme have been determined. These structures, together with extensive solution probing, have suggested that a significant conformational change accompanies catalysis. A recent crystal structure of a trans-acting precursor, obtained at low pH and by molecular replacement from the previous product conformation, conforms to the product, raising the possibility that it represents an activated conformer past the conformational change. Here, using fluorescence resonance energy transfer (FRET), we discovered that cleavage of this ribozyme at physiological pH is accompanied by a structural lengthening in magnitude comparable to previous trans-acting HDV ribozymes. Conformational heterogeneity observed by FRET in solution appears to have been removed upon crystallization. Analysis of a total of 1.8 µsec of molecular dynamics (MD) simulations showed that the crystallographically unresolved cleavage site conformation is likely correctly modeled after the hammerhead ribozyme, but that crystal contacts and the removal of several 2'-oxygens near the scissile phosphate compromise catalytic in-line fitness. A cis-acting version of the ribozyme exhibits a more dynamic active site, while a G-1 residue upstream of the scissile phosphate favors poor fitness, allowing us to rationalize corresponding changes in catalytic activity. Based on these data, we propose that the available crystal structures of the HDV ribozyme represent intermediates on an overall rugged RNA folding free-energy landscape.
- 650 _2
- $a katalýza $7 D002384
- 650 _2
- $a katalytická doména $7 D020134
- 650 _2
- $a krystalografie rentgenová $7 D018360
- 650 _2
- $a rezonanční přenos fluorescenční energie $x metody $7 D031541
- 650 _2
- $a virus hepatitidy delta $x enzymologie $x genetika $7 D003698
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a simulace molekulární dynamiky $7 D056004
- 650 _2
- $a konformace nukleové kyseliny $7 D009690
- 650 _2
- $a štěpení RNA $7 D059367
- 650 _2
- $a RNA katalytická $x chemie $7 D016337
- 650 _2
- $a RNA malá jaderná $x chemie $x metabolismus $7 D012342
- 650 _2
- $a RNA virová $x chemie $7 D012367
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a Research Support, U.S. Gov't, Non-P.H.S. $7 D013486
- 700 1_
- $a Tay, Wendy W $u Program in Chemical Biology, University of Michigan, Ann Arbor, Michigan 48109-1055, USA.
- 700 1_
- $a Banáš, Pavel $u Regional Centre of Advance Technologies and Materials, Department of Physical Chemistry, Faculty of Science, Palacký University, 771 46 Olomouc, Czech Republic.
- 700 1_
- $a Otyepka, Michal $u Regional Centre of Advance Technologies and Materials, Department of Physical Chemistry, Faculty of Science, Palacký University, 771 46 Olomouc, Czech Republic.
- 700 1_
- $a Šponer, Jiří $u Institute of Biophysics, Academy of Sciences of the Czech Republic, 612 65 Brno, Czech Republic Masaryk University, Campus Bohunice, 625 00 Brno, Czech Republic.
- 700 1_
- $a Walter, Nils G $u Department of Chemistry, Single Molecule Analysis Group, University of Michigan, Ann Arbor, Michigan 48109-1055, USA.
- 773 0_
- $w MED00006007 $t RNA (New York, N.Y.) $x 1469-9001 $g Roč. 20, č. 7 (2014), s. 1112-28
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24854621 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20141006 $b ABA008
- 991 __
- $a 20161101111554 $b ABA008
- 999 __
- $a ok $b bmc $g 1042082 $s 873111
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 20 $c 7 $d 1112-28 $i 1469-9001 $m RNA $n RNA $x MED00006007
- LZP __
- $a Pubmed-20141006